All bills
H.R. 6682·119th Congress·House Bill

Endometriosis CARE Act

IntroducedTrack

Latest action (11 Dec 2025): Introduced

What this bill does

H.R. 6682, the Endometriosis CARE Act, would direct federal health agencies to expand efforts on endometriosis research, data collection, and public education. It would authorize the National Institutes of Health to fund research, treatment studies, and an online clearinghouse of endometriosis information, with $50 million authorized annually for fiscal years 2026–2030. The Department of Health and Human Services would be required to study barriers patients face in accessing treatment—including through Medicaid, CHIP, and private insurance data—and report findings to Congress within two years. The bill also funds public education campaigns, provider-focused information on diagnosis and care, and a National Academies of Sciences study examining disparities in endometriosis diagnosis and treatment by race, geography, language, disability, sexual orientation, gender identity, and insurance status.

The bill primarily affects patients with endometriosis, particularly those from racial, ethnic, and other underserved groups; health care providers and systems; Medicaid and CHIP programs; and private insurers, who could be required to report data on treatment access. It aims to improve awareness, research funding, and identification of disparities in care, without creating new mandates for insurance coverage itself.

The bill was introduced on December 11, 2025, by Rep. Nikema Williams and referred to the House Committee on Energy and Commerce. As an introduced bill, it has not yet received a committee vote, floor vote, or Senate action, and its future consideration is not yet determined.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Official summary

This bill is in the first stage of the legislative process. It was introduced into Congress on December 11, 2025. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.

Common questions

What does H.R. 6682 do?
H.R. 6682, the Endometriosis CARE Act, would direct federal health agencies to expand efforts on endometriosis research, data collection, and public education. It would authorize the National Institutes of Health to fund research, treatment studies, and an online clearinghouse of endometriosis information, with $50 million authorized annually for fiscal years 2026–2030. The Department of Health and Human Services would be required to study barriers patients face in accessing treatment—including through Medicaid, CHIP, and private insurance data—and report findings to Congress within two years. The bill also funds public education campaigns, provider-focused information on diagnosis and care, and a National Academies of Sciences study examining disparities in endometriosis diagnosis and treatment by race, geography, language, disability, sexual orientation, gender identity, and insurance status. The bill primarily affects patients with endometriosis, particularly those from racial, ethnic, and other underserved groups; health care providers and systems; Medicaid and CHIP programs; and private insurers, who could be required to report data on treatment access. It aims to improve awareness, research funding, and identification of disparities in care, without creating new mandates for insurance coverage itself. The bill was introduced on December 11, 2025, by Rep. Nikema Williams and referred to the House Committee on Energy and Commerce. As an introduced bill, it has not yet received a committee vote, floor vote, or Senate action, and its future consideration is not yet determined.
Has H.R. 6682 become law?
Not yet. As of 11 Dec 2025, H.R. 6682 is introduced.
Who sponsored H.R. 6682?
H.R. 6682 was sponsored by Rep. Nikema Williams [D-GA5] (Democrat-GA), with 27 cosponsors.
What's the latest action on H.R. 6682?
Introduced (11 Dec 2025).

Related bills in Health

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.